Sarda Proteins Surges with Unprecedented Buying Interest, Hits Upper Circuit

Exceptional Buying Pressure Drives Stock to Upper Circuit

On 28 Nov 2025, Sarda Proteins Ltd, a key player in the edible oil sector, demonstrated a striking market phenomenon as it surged by 4.98% in a single trading session, outperforming the Sensex which recorded a marginal 0.08% gain. The stock opened at Rs 84.4 and maintained this price throughout the day, touching an intraday high that matched the upper circuit limit. Notably, the trading activity was characterised by an absence of sellers, with only buy orders queued up, a rare occurrence that underscores the intense demand for the stock.

This buying frenzy has propelled Sarda Proteins into a unique position where the stock price remains locked at the upper circuit, reflecting a scenario where supply is unable to meet the overwhelming demand. Such a situation often indicates strong market conviction and can lead to sustained price momentum over multiple sessions.

Consecutive Gains Highlight Sustained Investor Interest

The current rally in Sarda Proteins is not an isolated event. The stock has been on a consistent upward trajectory for the past six trading days, delivering a cumulative return of 33.84% during this period. This streak of gains contrasts sharply with the broader market trends, where the Sensex has shown more modest movements. Over the past week, Sarda Proteins outperformed the Sensex by a significant margin, registering a 27.47% increase compared to the benchmark’s 0.65% rise.

Such sustained buying interest over multiple sessions suggests a shift in market assessment towards the company, with investors possibly anticipating favourable developments or recognising value in the stock’s current price action. The absence of sellers further amplifies the bullish sentiment, creating a supply-demand imbalance that supports the upper circuit scenario.

Price and Moving Average Analysis

From a technical perspective, Sarda Proteins’ current price of Rs 84.4 sits above its 5-day, 100-day, and 200-day moving averages, indicating short- and long-term support levels are intact. However, it remains below the 20-day and 50-day moving averages, suggesting some resistance zones that the stock may need to overcome to sustain its upward momentum. The gap-up opening today by nearly 5% further emphasises the strong buying interest and positive market sentiment surrounding the stock.

Comparative Performance Over Various Timeframes

While the recent short-term performance of Sarda Proteins has been robust, a broader look at its historical returns presents a mixed picture. Over the past month and three months, the stock price has remained flat at 0.00%, whereas the Sensex recorded gains of 1.37% and 7.13% respectively during the same periods. This indicates that the recent surge is a relatively new development after a period of consolidation.

On a longer horizon, the stock’s one-year performance shows a decline of 21.74%, contrasting with the Sensex’s 8.53% gain. Year-to-date, Sarda Proteins has not recorded any price change, while the Sensex advanced by 9.79%. Over three years, the stock has seen a significant reduction of 48.14%, whereas the benchmark index appreciated by 37.25%. However, the five-year performance tells a different story, with Sarda Proteins delivering a substantial 788.42% return, far outpacing the Sensex’s 94.31% growth over the same period.

These figures highlight the stock’s volatile journey, with periods of strong growth interspersed with phases of stagnation and decline. The current buying interest and upper circuit status may signal a potential turning point in this trajectory.

Sector and Market Context

Sarda Proteins operates within the edible oil industry, a sector that has experienced varied market dynamics influenced by commodity prices, regulatory changes, and consumer demand patterns. The stock’s outperformance relative to its sector peers and the broader market today suggests a renewed focus from investors, possibly driven by company-specific developments or shifts in sector fundamentals.

Given the stock’s market capitalisation grade of 3, it occupies a mid-tier position in terms of market size within its sector, which may attract investors looking for growth opportunities in smaller or mid-cap stocks with potential for price appreciation.

Potential for Multi-Day Upper Circuit Scenario

The current trading pattern of Sarda Proteins, characterised by an absence of sellers and a queue of buy orders at the upper circuit price, raises the possibility of the stock remaining in this state for multiple sessions. Such multi-day upper circuit scenarios are often driven by strong investor conviction, positive sentiment, or anticipation of favourable news flow.

While this creates an environment of heightened volatility and limited liquidity for sellers, it also reflects a market consensus that the stock’s valuation is poised for upward revision. Investors should monitor trading volumes and price action closely in the coming days to gauge whether this momentum sustains or if profit-taking emerges once the circuit limits are lifted.

Investor Considerations and Market Outlook

For market participants, the extraordinary buying interest in Sarda Proteins presents both opportunities and risks. The stock’s recent performance and technical positioning suggest potential for further gains, especially if the multi-day circuit scenario unfolds. However, the historical volatility and mixed longer-term returns warrant a cautious approach, with attention to broader market conditions and sector developments.

Investors may also consider the company’s fundamentals and any recent changes in analytical perspectives that could be influencing market sentiment. The edible oil sector’s dynamics, including raw material costs and regulatory environment, remain key factors that could impact future performance.

Summary

Sarda Proteins has captured market attention with a striking surge to the upper circuit, driven by exclusive buy orders and a six-day streak of gains amounting to over 33%. This exceptional demand, coupled with the stock’s technical positioning above key moving averages, signals strong investor interest and the potential for continued momentum. While the broader historical performance shows variability, the current market behaviour suggests a shift in sentiment that could influence the stock’s trajectory in the near term.

As the edible oil sector navigates its own challenges and opportunities, Sarda Proteins stands out as a stock to watch, particularly given the possibility of a multi-day upper circuit scenario. Market participants should remain vigilant to evolving price action and sector trends to make informed decisions.

Get 1 year of Weekly Picks FREE when you subscribe to MojoOne. Offer ends soon. Start Saving Now →